Long-term effects of homologous and heterologous SARS-CoV-2 vaccination on humoral and cellular immune responses
Allergy
.
2022 Aug;77(8):2560-2564.
doi: 10.1111/all.15373.
Epub 2022 May 25.
Authors
Moritz M Hollstein
1
,
Lennart Münsterkötter
2
,
Michael P Schön
1
3
,
Armin Bergmann
1
,
Thea M Husar
1
,
Anna Abratis
4
,
Abass Eidizadeh
4
,
Sascha Dierks
4
,
Meike Schaffrinski
1
,
Karolin Zachmann
1
,
Anne Schmitz
5
,
Jason S Holsapple
5
,
Hedwig Stanisz-Bogeski
1
,
Julie Schanz
4
6
,
Andreas Fischer
4
7
,
Uwe Groß
2
,
Andreas Leha
8
,
Andreas E Zautner
2
9
,
Moritz Schnelle
4
,
Luise Erpenbeck
1
5
Affiliations
1
Department of Dermatology, Venereology and Allergology, University Medical Center Göttingen, Göttingen, Germany.
2
Institute of Medical Microbiology and Virology, University Medical Center Göttingen, Göttingen, Germany.
3
Lower Saxony Institute of Occupational Dermatology, University Medical Center Göttingen, Göttingen, Germany.
4
Institute for Clinical Chemistry, University Medical Center Göttingen, Göttingen, Germany.
5
Department of Dermatology, University of Münster, Münster, Germany.
6
Department of Hematology and Medical Oncology, University Medical Center Göttingen, Göttingen, Germany.
7
Division Vascular Signaling and Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany.
8
Department of Medical Statistics, University Medical Center Göttingen, Göttingen, Germany.
9
Institute of Medical Microbiology and Hospital Hygiene, Medical Faculty, Otto-von-Guericke University Magdeburg, Magdeburg, Germany.
PMID:
35567394
PMCID:
PMC9348463
DOI:
10.1111/all.15373
No abstract available
Publication types
Letter
Research Support, Non-U.S. Gov't
MeSH terms
COVID-19 Vaccines
COVID-19* / prevention & control
Humans
Immunity, Cellular
Immunity, Humoral
SARS-CoV-2*
Vaccination
Substances
COVID-19 Vaccines